1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2015

Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, ?Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2015" provides data on the Progressive Supranuclear Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Progressive Supranuclear Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Progressive Supranuclear Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Progressive Supranuclear Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Progressive Supranuclear Palsy 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Progressive Supranuclear Palsy Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Westat, Inc. 26
Clinical Trial Overview of Westat, Inc. 26
TauRx Pharmaceuticals Ltd. 27
Clinical Trial Overview of TauRx Pharmaceuticals Ltd. 27
Sellas Inc. 28
Clinical Trial Overview of Sellas Inc. 28
Paladin Labs Inc. 29
Clinical Trial Overview of Paladin Labs Inc. 29
Noscira, S.A. 30
Clinical Trial Overview of Noscira, S.A. 30
Mithridion, Inc. 31
Clinical Trial Overview of Mithridion, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
University of California, San Francisco 32
Clinical Trial Overview of University of California, San Francisco 32
Centre Hospitalier Universitaire de Nantes 33
Clinical Trial Overview of Centre Hospitalier Universitaire de Nantes 33
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 34
Clinical Trial Overview of Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 34
Georgetown University Medical Center 35
Clinical Trial Overview of Georgetown University Medical Center 35
German Parkinson Association e.V. 36
Clinical Trial Overview of German Parkinson Association e.V. 36
Groupe Hospitalier Pitie-Salpetriere 37
Clinical Trial Overview of Groupe Hospitalier Pitie-Salpetriere 37
King's College London 38
Clinical Trial Overview of King's College London 38
Ludwig Maximilians Universitat Munich 39
Clinical Trial Overview of Ludwig Maximilians Universitat Munich 39
National Institute of Neurological Disorders and Stroke 40
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 40
Five Key Clinical Profiles 41
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 13
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Progressive Supranuclear Palsy Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Westat, Inc., 2015* 26
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by TauRx Pharmaceuticals Ltd., 2015* 27
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sellas Inc., 2015* 28
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Paladin Labs Inc., 2015* 29
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Noscira, S.A., 2015* 30
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mithridion, Inc., 2015* 31
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 32
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nantes, 2015* 33
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 2015* 34
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University Medical Center, 2015* 35
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by German Parkinson Association e.V., 2015* 36
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Hospitalier Pitie-Salpetriere, 2015* 37
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College London, 2015* 38
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig Maximilians Universitat Munich, 2015* 39
Progressive Supranuclear Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 40

List of Figures
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 13
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 56

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.